SIMEONE, Claudio
 Distribuzione geografica
Continente #
NA - Nord America 22.821
EU - Europa 14.988
AS - Asia 14.164
SA - Sud America 3.033
AF - Africa 264
OC - Oceania 44
Continente sconosciuto - Info sul continente non disponibili 34
Totale 55.348
Nazione #
US - Stati Uniti d'America 22.422
CN - Cina 4.732
SG - Singapore 4.423
UA - Ucraina 3.562
PL - Polonia 2.631
BR - Brasile 2.569
IT - Italia 2.472
DE - Germania 2.196
HK - Hong Kong 1.997
VN - Vietnam 1.075
FI - Finlandia 1.023
FR - Francia 742
RU - Federazione Russa 673
TR - Turchia 665
IE - Irlanda 583
GB - Regno Unito 563
IN - India 422
CA - Canada 206
AR - Argentina 176
SE - Svezia 132
ID - Indonesia 131
BD - Bangladesh 128
ZA - Sudafrica 110
MX - Messico 108
IQ - Iraq 93
EC - Ecuador 85
BE - Belgio 77
JP - Giappone 72
NL - Olanda 70
IR - Iran 67
PK - Pakistan 62
AT - Austria 58
ES - Italia 56
SA - Arabia Saudita 56
CO - Colombia 45
VE - Venezuela 45
AU - Australia 38
UZ - Uzbekistan 35
EU - Europa 34
MA - Marocco 33
PY - Paraguay 33
CZ - Repubblica Ceca 29
EG - Egitto 26
KE - Kenya 26
AE - Emirati Arabi Uniti 25
CL - Cile 24
TN - Tunisia 23
UY - Uruguay 22
JM - Giamaica 20
AZ - Azerbaigian 19
NP - Nepal 19
PE - Perù 18
IL - Israele 17
LT - Lituania 16
DZ - Algeria 15
MY - Malesia 15
JO - Giordania 14
TT - Trinidad e Tobago 14
BO - Bolivia 13
KZ - Kazakistan 13
PA - Panama 11
DO - Repubblica Dominicana 10
HN - Honduras 10
MU - Mauritius 10
RO - Romania 10
KG - Kirghizistan 9
OM - Oman 9
AL - Albania 8
CH - Svizzera 8
LV - Lettonia 8
PT - Portogallo 8
KR - Corea 7
NO - Norvegia 7
BY - Bielorussia 6
EE - Estonia 6
ET - Etiopia 6
MK - Macedonia 6
BH - Bahrain 5
CR - Costa Rica 5
DK - Danimarca 5
LA - Repubblica Popolare Democratica del Laos 5
MD - Moldavia 5
PH - Filippine 5
PS - Palestinian Territory 5
SK - Slovacchia (Repubblica Slovacca) 5
SN - Senegal 5
SY - Repubblica araba siriana 5
BB - Barbados 4
BG - Bulgaria 4
GT - Guatemala 4
KH - Cambogia 4
LB - Libano 4
NG - Nigeria 4
NZ - Nuova Zelanda 4
TH - Thailandia 4
AM - Armenia 3
AO - Angola 3
BA - Bosnia-Erzegovina 3
GE - Georgia 3
GR - Grecia 3
Totale 55.304
Città #
Warsaw 2.620
Fairfield 2.582
Jacksonville 2.467
Ashburn 2.111
Singapore 2.008
Hong Kong 1.994
Woodbridge 1.736
Princeton 1.115
Beijing 1.099
Houston 1.060
Cambridge 1.054
Seattle 1.041
Wilmington 983
Ann Arbor 899
Nanjing 731
Chandler 619
Dublin 579
Helsinki 534
New York 522
Istanbul 513
Los Angeles 445
Ho Chi Minh City 343
Nanchang 307
The Dalles 300
Munich 285
Dearborn 250
Des Moines 246
São Paulo 237
Moscow 222
Redondo Beach 214
Buffalo 211
Shenyang 205
Dong Ket 196
Milan 194
Changsha 189
Hanoi 171
San Diego 161
Hebei 152
Shanghai 148
Tianjin 148
Jinan 138
Dallas 133
Brescia 126
Rome 125
Turku 123
Jiaxing 110
San Francisco 110
Rio de Janeiro 97
Kunming 91
Toronto 88
Chicago 85
Santa Clara 83
Verona 75
Brussels 71
Kocaeli 69
Zhengzhou 69
Johannesburg 68
London 68
Guangzhou 66
Jakarta 64
Washington 63
Hangzhou 62
Denver 59
Boardman 58
Nürnberg 57
Tokyo 56
Atlanta 55
San Mateo 55
Montreal 54
Ardabil 53
Brooklyn 53
Belo Horizonte 52
Falkenstein 51
Augusta 50
Monmouth Junction 47
Phoenix 45
Lanzhou 44
Norwalk 43
Chennai 42
Da Nang 42
Brasília 41
Ningbo 40
Frankfurt am Main 39
Porto Alegre 38
Stockholm 38
Curitiba 36
Poplar 36
Ankara 34
Boston 34
Mexico City 34
Nuremberg 34
Orem 34
Campinas 33
Düsseldorf 33
Baghdad 32
Leawood 31
Tashkent 31
Bologna 30
Haikou 30
Lancaster 30
Totale 34.479
Nome #
Reflusso vescico ureterale nel rene trapiantato 352
INCONTINENZA URINARIA NELL'ANZIANO da Linee guida sull'incontinenza 4° Consultazione internazionale sull'incontinenza- Raccomandazioni ICI 2009 (traduzione in lingua italiana) 351
Complex Relationships between Occupation, Environment, DNA Adducts, Genetic Polymorphisms and Bladder Cancer in a Case-Control Study Using a Structural Equation Modeling. 285
GPNMB/OA protein increases the invasiveness of human metastatic prostate cancer cell lines DU145 and PC3 through MMP-2 and MMP-9 activity 282
Usefulness of sacral nerve modulation in a series of multiple sclerosis patients with bladder dysfunction 281
Patient's adherence on pharmacological therapy for benign prostatic hyperplasia (BPH)-associated lower urinary tract symptoms (LUTS) is different: Is combination therapy better than monotherapy 275
Laparoscopic and robotic ureteral stenosis repair: a multi-institutional experience with a long-term follow-up 272
CALCOLOSI MOLLE CALICEALE: UN CASO DI DIFFICILE DIAGNOSI 267
REIMPIANTO URETERALE LAPAROSCOPICO ROBOT-ASSISTED PER REFLUSSO VESCICO URETERALE RECIDIVO A INFILTRAZIONE CON MACROPLASTIQUE 261
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: the Pros-IT CNR study 233
Below Safety Limits, Every Unit of Glomerular Filtration Rate Counts: Assessing the Relationship Between Renal Function and Cancer-specific Mortality in Renal Cell Carcinoma 231
External validation of the preoperative Karakiewicz nomogram in a large multicentre series of patients with renal cell carcinoma 221
Biological effect of neoadjuvant androgen-deprivation therapy assessed on specimens from radical prostatectomy: a systematic review 221
[ProACT (Adjustable Continence Therapy) implants in case of failure of other techniques for urinary incontinence]. 221
Robot-assisted Partial Nephrectomy and Bilateral Pyelolithotomy in Ectopic Pelvic Kidneys 212
The impact of completeness of last transurethral resection of bladder tumors on the outcomes of radical cystectomy 211
Caratterizzazione dei linfonodi retroperitoneali in risonanza magnetica con mezzo di contrasto linfonodo specifico (AMI227): confronto con l'istologia 207
Pros-IT CNR: an Italian prostate cancer monitoring project 206
Differences in trends in the use of robot-assisted and open radical cystectomy and changes over time in peri-operative outcomes among selected centres in North America and Europe: an international multicentre collaboration 206
Outcomes of Partial and Radical Nephrectomy in Octogenarians – A Multicenter International Study (Resurge) 204
Positive Surgical Margins Predict Progression-free Survival After Nephron-sparing Surgery for Renal Cell Carcinoma: Results From a Single Center Cohort of 459 Cases With a Minimum Follow-up of 5 Years 190
How to improve patient selection for neoadjuvant chemotherapy in bladder cancer patients candidate for radical cystectomy and pelvic lymph node dissection 189
Robotic partial nephrectomy versus radical nephrectomy in elderly patients with large renal masses 188
[Acetylcholine induces human detrusor muscle cell proliferation: molecular and pharmacological characterization.] 184
Long-term Prognostic Impact of Chromosome Abnormalities in Clear Cell Renal Cell Carcinoma 182
I recettori muscarinici stimolano la proliferazione di leiomiociti derivati da muscolo detrusore umano 178
Inhibition of Survivin Is Associated with Zoledronic Acid-induced Apoptosis of Prostate Cancer Cells 178
OUTCOMES OF PREVENTIVE VS DELAYED LIGATION OF DORSAL VASCULAR COMPLEX DURING RARP: PRELIMINARY RESULTS OF A RANDOMIZED TRIAL 173
The Simplified PADUA REnal (SPARE) nephrometry system: a novel classification of parenchymal renal tumours suitable for partial nephrectomy 172
Different muscarinic receptor subtypes modulate proliferation of primary human detrusor smooth muscle cells via Akt/PI3K and map kinases. 171
Biological bases of radical prostatectomy in the management of prostate cancer patients with oligometastatic disease 170
DISCRIMINATION ABILITY OF THE SURFACE-INTERMEDIATE-BASE MARGIN (SIB) SCORE: AN EXTERNAL HISTOPATHOLOGICAL EVALUATION 169
[Ductal carcinoma of the prostate: impact on survival and therapeutic controversies of a rare tumor]. 168
18F-FDG PET/CT in a Patient Affected by Renal Collecting Duct (Bellini) Carcinoma 168
Elective Nephron Sparing Surgery Decreases Other Cause Mortality Relative to Radical Nephrectomy Only in Specific Subgroups of Patients with Renal Cell Carcinoma 168
[Insignificant prostate cancer: charateristics and predictive factors]. 167
THE ROLE OF PRIMARY SURGERY AND EXTERNAL BEAM RADIATION THERAPY IN THE MANAGEMENT OF NON-METASTATIC DUCTAL PROSTATE CANCER: 20-YEAR OUTCOMES FROM A SINGLE INSTITUTION EXPERIENCE 167
[High-intensity focused ultrasound (HIFU): our experience in the treatment of prostate cancer relapsing after radiotherapy]. 166
CAVECTOMIA PER INFILTRAZIONE NEOPLASTICA DA NEOPLASIA RENALE PARENCHIMALE DESTRA 165
Validation of the 2009 TNM version in a large multi-institutional cohort of patients treated for renal cell carcinoma: Are further improvements needed? 165
Approccio anatomo-clinico alla patologia della prostata 164
Venous tumor thrombus consistency is not predictive of survival in patients with renal cell carcinoma: A retrospective study of 147 patients 164
Upstaging to pT3a disease in patients undergoing robotic partial nephrectomy for cT1 kidney cancer: Outcomes and predictors from a multi-institutional dataset 163
External histopathological validation of the surface-intermediate-base margin score 163
Pre-existing type-2 diabetes is not an adverse prognostic factor in patients with renal cell carcinoma: A single-center retrospective study. 162
[Differences in morbidity of neobladder versus ileal conduit: a matched pair analysis on 134 patients] 162
PATHOGENESIS, FEATURES AND PROGNOSIS OF RENAL RELAPSE AFTER PARTIAL NEPHRECTOMY 162
A SNAPSHOT OF NEPHRON SPARING SURGERY IN ITALY: A PROSPECTIVE, MULTICENTER REPORT ON CLINICAL AND PERIOPERATIVE OUTCOMES (THE RECORD 1 PROJECT) 162
Analysis of Circulating Tumor Cells in Prostate Cancer Patients at PSA Recurrence and Review of the Literature 162
Features of Ipsilateral Renal Recurrences After Partial Nephrectomy: A Proposal of a Pathogenetic Classification 162
Robotic versus other nephroureterectomy techniques: a systematic review and meta-analysis of over 87,000 cases 161
MUSCARINIC RECEPTORS STIMULATE CELL PROLIFERATION IN THE HUMAN UROTHELIUM-DERIVED CELL LINE UROtsa 160
MP34-09 IS A DELAY IN THE TIMING OF RADICAL CYSTECTOMY REALLY DETRIMENTAL? A RETROSPECTIVE STUDY ON A SINGLE CENTRE COHORT 160
PATHOGENESIS, FEATURES AND PROGNOSIS OF RENAL RELAPSE AFTER PARTIAL NEPHRECTOMY 160
Impact of Tumor Size on Cancer-Specific Mortality Rate after Local Tumor Ablation in T1a Renal-Cell Carcinoma 159
Prognostic factors in a large multi-institutional series of papillary renal cell carcinoma. 158
Serum vitamin D and prostate cancer prognosis: The story continues 157
TERAPIA ENDOCAVITARIA DI SECONDA LINEA CON GEMCITABINA NELLA NEOPLASIA VESCICALE NON MUSCOLO INVASIVA RECIDIVA AD ALTO RISCHIO 156
VENOUS TUMOR THROMBUS CONSISTENCY IS NOT PREDICTIVE OF SURVIVAL IN PATIENTS WITH RENAL CELL CARCINOMA: A RETROSPECTIVE STUDY ON 147 PATIENTS 155
Hyper-Activation of STAT3 Sustains Progression of Non-Papillary Basal-Type Bladder Cancer via FOSL1 Regulome 155
Prediction tools in non-muscle invasive bladder cancer 155
[Sliding-clip robotic nephropexy]. 154
Features, risk factors and clinical outcome of "very late" recurrences after surgery for localized renal carcinoma: A retrospective evaluation of a cohort with a minimum of 10 years of follow up 154
End-Stage Renal Disease After Renal Surgery in Patients with Normal Preoperative Kidney Function: Balancing Surgical Strategy and Individual Disorders at Baseline 154
Surgically-induced hypertension and cardiovascular morbidity following treatment for localized kidney cancer: the impact of nephrons loss 154
Predictors of the Transition from Off to On Clamp Approach during Ongoing Robotic Partial Nephrectomy: Data from the CLOCK Randomized Clinical Trial 154
Nephron-Sparing Surgery versus Radical Nephrectomy in the Treatment of Intracapsular Renal Cell Carcinoma up to 7 cm 154
Comparison of Perioperative Morbidity of Radical Cystectomy with Neobladder Versus Ileal Conduit: A Matched Pair Analysis of 170 Patients 153
Standard vs delayed ligature of the dorsal vascular complex during robot-assisted radical prostatectomy: results from a randomized controlled trial 152
[Intrinsic ureteral endometriosis: description of a striking instance.] 151
Alpha1 adrenoceptor subtypes in human urinary bladder: sex and regional comparison. 150
A snapshot of nephron-sparing surgery in Italy: A prospective, multicenter report on clinical and perioperative outcomes (the RECORd 1 project) 150
Reply by Authors 150
Conditional survival of patients with nonmetastatic renal cell carcinoma: How cancer-specific mortality changes after nephrectomy 149
Renal Function Impairment Below Safety Limits Correlates With Cancer-specific Mortality in Localized Renal Cell Carcinoma: Results From a Single-center Study 149
Complication rates, failure to rescue and in-hospital mortality after cytoreductive nephrectomy in the older patients 149
Role of F18-FDG-PET/CT in restaging patients affected by renal carcinoma 148
TRATTAMENTO CON EMBOLIZZAZIONE SUPERSELETTIVA DEL PRIAPISMO AD ALTO FLUSSO DA FISTOLA ARTERO-CAVERNOSA 148
The R.E.N.A.L. Nephrometric Nomogram Cannot Accurately Predict Malignancy or Aggressiveness of Small Renal Masses Amenable to Partial Nephrectomy. 147
Holographic Reconstructions for Preoperative Planning before Partial Nephrectomy: A Head-to-Head Comparison with Standard CT Scan 147
Perioperative Outcomes of Open, Laparoscopic, and Robotic Partial Nephrectomy: A Prospective Multicenter Observational Study (The RECORd 2 Project) 146
DRENAGGIO PERCUTANEO TRANSPERINEALE ECOGUIDATO DEGLI ASCESSI PROSTATICI Transperitoneal percutaneous echo-guided drainage of prostatic abscesses 145
The follow-up management of non-metastatic renal cell carcinoma: Definition of a surveillance protocol 145
A prospective, multicenter evaluation of predictive factors for positive surgical margins after nephron-sparing surgery for renal cell carcinoma: The record1 italian project 144
VARIATIONS IN RENAL CORTEX VOLUMES BEFORE AND AFTER PARTIAL NEPHRECTOMY: A PILOT STUDY ON 30 CASES 144
Patient frailty predicts worse perioperative outcomes and higher cost after radical cystectomy worse radical cystectomy outcomes in frails 143
[Renal cell carcinoma associated with incidental presentation of renal artery aneurysm: surgical management.] 141
Analysis of radical cystectomy and urinary diversion complications with the Clavien classification system in an Italian real life cohort. 141
Predictive Value of Nephrometry Scores in Nephron-sparing Surgery: A Systematic Review and Meta-analysis 141
Histological variants in non-muscle invasive bladder cancer 141
Partial Nephrectomy in Clinical T1b Renal Tumors: Multicenter Comparative Study of Open, Laparoscopic and Robot-assisted Approach (the RECORd Project) 141
Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series 140
Riparazione di fistola vescico-rettale secondo la tecnica di york mason 139
A multicentre matched-pair analysis comparing robot-assisted versus open partial nephrectomy. 139
DISCRIMINATION ABILITY OF TH SURFACE-INTERMEDIATE-BASE MARGIN :(SIB) SCORE: AN EXTERNAL HISTOPATHOLOGICAL EVALUATION 139
Impact of Surgical Approach on Patient-Reported Outcomes after Radical Prostatectomy: A Propensity Score-Weighted Analysis from a Multicenter, Prospective, Observational Study (The Pros-IT CNR Study) 139
Minimally Invasive Radical Prostatectomy after Previous Bladder Outlet Surgery: A Systematic Review and Pooled Analysis of Comparative Studies 139
[Did the staging of renal neoplasm improve with time? Retrospective study on a cohort of 2000 patients]. 138
Adherence to the EAU guidelines on Penile Cancer Treatment: European, multicentre, retrospective study 138
LA DIFFERENZIAZIONE SARCOMATOIDE INFLUENZA NEGATIVAMENTE LA PROGNOSI NEI PAZIENTI AFFETTI DA CARCINOMA A CELLULE RENALI INDIPENDENTEMENTE DALL'ISTOTIPO 137
Totale 17.526
Categoria #
all - tutte 266.974
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 266.974


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20215.930 0 0 0 0 0 1.071 377 1.136 1.070 964 860 452
2021/20224.045 293 789 78 243 70 169 134 315 223 522 312 897
2022/20232.664 600 58 77 102 178 804 20 205 299 36 147 138
2023/20243.980 185 71 243 412 186 666 137 127 1.137 89 64 663
2024/20258.455 81 55 29 1.182 912 759 821 233 880 650 1.779 1.074
2025/202610.396 1.602 2.420 1.404 2.782 1.617 571 0 0 0 0 0 0
Totale 56.107